TREM2 and Alzheimer disease: In a newly developed mouse model of genetic risk for sporadic or late-onset Alzheimer’s disease (LOAD mice) transgenic mice express humanized APOE4 and TREM2 (Oblak et al., 2021; Oblak et al., 2022) alongside a humanized beta-amyloid precursor protein.